Reviewed profile

food and beverage brand · public preview

Vyvanse

Retail brand

Public category
Retail brand
Brand tier
mainstream brand
Headquarters
Japan
Is this your company?Claim Vyvanse to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Vyvanse — no cold outreach.
Report a changeLog in for full recordLast reviewed 2 Jun 2026 · public preview data

Overview

What Vyvanse covers.

Vyvanse is a prescription medication containing lisdexamfetamine dimesylate, indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) and moderate to severe binge eating disorder. It is a central nervous system stimulant manufactured and marketed by Takeda Pharmaceutical Company Limited. The medication is intended for use under the supervision of healthcare professionals.

  • Positioned as a mainstream brand.
  • Headquartered in Japan.

FAQ

Questions this page answers.

What does Vyvanse do?

Vyvanse is a food and beverage brand based in Japan, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.